Behandlungsoptionen für Morbus Fabry

Patent europeic · EP2533050 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2533050
Numer da la dumonda
EP12168451
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Limità
Annunzià
16-05-2007
Publitgà
12-12-2012
Concedì
12-03-2014
La protecziun finescha il pli tard
15-05-2027
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
G01N 33/53 (2006.01)
G01N 33/567 (2006.01)
G01N 33/573 (2006.01)
A61K 31/435 (2006.01)
Prioritad
US 801089 P 16.05.2006
US 853631 P 23.10.2006
Derivà da
EP07797506
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  4. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  5. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  6. 24-06-2015

    Midada

    Published in Swissreg on 24.06.2015

  7. 12-03-2014

    Concedì

    Published in Swissreg on 12.03.2014

Partidas

Possessur

AMICUS THERAPEUTICS, INC.

Amicus Therapeutics, Inc.

1 Cedar Brook Drive, Cranbury, NJ 08512, US

National Institutes of Health

NATIONAL INSTITUTES OF HEALTH

10 Center Drive, Bethesda MD 20892-1260, US

Inventur

Lockhart, David

Cranbury, NJ 08512, US

Castelli, Jeff

Cranbury, NJ 08512, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.